Amphastar Pharmaceuticals (AMPH) Inventory Average (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Inventory Average of $173.5 million for Q1 2026, up 2.32% year-over-year from $169.6 million in Q1 2025, and down 4.34% quarter-over-quarter from $181.4 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Inventory Average (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Inventory Average history runs 13 years deep, the most recent figure standing at $173.5 million for Q1 2026.
- In Q1 2026, Inventory Average rose 2.32% year-over-year to $173.5 million; the TTM figure through Mar 2026 stood at $173.5 million (up 2.32% YoY), while the FY2025 annual figure was $165.3 million, up 27.37% from the prior year.
- Inventory Average for Q1 2026 stood at $173.5 million, down from $181.4 million in the prior quarter.
- The five-year high for Inventory Average was $188.8 million in Q3 2025, with the low at $94.0 million in Q1 2022.
- The 5-year median for Inventory Average is $110.7 million (2024), against an average of $130.5 million.
- The sharpest annual moves came in 2022 and 2025: Inventory Average fell 3.09% in 2022, then jumped 58.55% in 2025.
- Amphastar Pharmaceuticals' Inventory Average stood at $103.4 million in 2022, then rose by 4.34% to $107.9 million in 2023, then surged by 31.62% to $142.0 million in 2024, then climbed by 27.73% to $181.4 million in 2025, then fell by 4.34% to $173.5 million in 2026.
- Business Quant data shows AMPH's Inventory Average at $173.5 million in Q1 2026, $181.4 million in Q4 2025, and $188.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 175.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 175.05 Mn |
| Mar 31, 2026 | 173.54 Mn |
| Dec 31, 2025 | 181.41 Mn |
| Sep 30, 2025 | 188.83 Mn |
| Jun 30, 2025 | 188.60 Mn |
| Mar 31, 2025 | 169.61 Mn |
| Dec 31, 2024 | 142.03 Mn |
| Sep 30, 2024 | 126.36 Mn |
| Jun 30, 2024 | 118.95 Mn |
| Mar 31, 2024 | 110.66 Mn |
| Dec 31, 2023 | 107.91 Mn |
| Sep 30, 2023 | 107.30 Mn |
| Jun 30, 2023 | 104.13 Mn |
| Mar 31, 2023 | 103.62 Mn |
| Dec 31, 2022 | 103.42 Mn |
| Sep 30, 2022 | 100.99 Mn |
| Jun 30, 2022 | 96.94 Mn |
| Mar 31, 2022 | 93.98 Mn |
| Dec 31, 2021 | 96.52 Mn |
| Sep 30, 2021 | 99.09 Mn |